News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. and Iran agreed to end hostilities, with a signing scheduled Friday in Switzerland.
  • Reported pact would reopen the Strait of Hormuz, easing oil-supply risk.
  • MOEX closed flat at a six-month low while the broader Russian market declined.
  • Gold rose and crude oil fell sharply, reflecting reduced Middle East military risk.
  • Crinetics reported positive Phase 2 Atumelnant data, supporting advancement to late-stage trials.
  • Bernstein found no AI shopping agent can complete unsupervised purchases without embedded payments or cross-retailer data.

Latest Articles

Xos Launches the 2.5MWh Power Hub, Delivering Grid-Independent Energy Storage to Data Centers in Days, Not Years

Xos Launches the 2.5MWh Power Hub, Delivering Grid-Independent Energy Storage to Data Centers in Days, Not Years

Xos, Inc. has introduced the 2.5MWh Power Hub series, a factory-integrated, rapidly deployable energy storage and hybrid power system designed to deliver megawatt-scale power within days, bypassing traditional 3 to 7 year US grid interconnection delays. Built on a proven platform with over 250 MWh deployed across North America, the Power Hub target…

Netskope Shares Rise After Company Joins Anthropic’s Project Glasswing

Netskope Shares Rise After Company Joins Anthropic’s Project Glasswing

Netskope Inc. saw its shares climb 4% in after-hours trading following an announcement that it has joined Anthropic’s Project Glasswing, gaining access to the Claude Mythos Preview model to help detect vulnerabilities in code. The company highlighted rapid enterprise adoption of AI, frequent AI data policy violations, and widespread gaps in AI acti…

Crescent Biopharma to Present at June Investor Conferences

Crescent Biopharma to Present at June Investor Conferences

Crescent Biopharma, a clinical-stage biotechnology company focused on cancer therapies, announced that its management will present at the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. The presentations will be webcast live and replayed on the company's investor website.

U.S. Targets Eastern Congo Commanders with Sanctions Amid Ongoing Fighting

U.S. Targets Eastern Congo Commanders with Sanctions Amid Ongoing Fighting

The United States Treasury Department announced sanctions on two commanders from opposing armed groups involved in the conflict in eastern Democratic Republic of Congo, citing continued violence and a worsening humanitarian crisis. The move comes amid stalled mediation efforts and after a December Washington peace agreement that was followed by ren…

BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Corp., a clinical-stage biotechnology company focused on cancer immunotherapies, announced the closing of a best-efforts offering of approximately 1.45 million common shares at $3.25 per share, raising gross proceeds of about $4.7 million. The funds will be used for working capital, general corporate purposes, and advancing bu…

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma announced key changes to its board of directors as part of its strategic evolution toward becoming a late-stage clinical company. Four independent directors resigned, and the company appointed Daniel Camardo, an experienced CEO with commercial launch success, and Viola Meehan, a seasoned CFO with extensive finance and governance exper…

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Vaxcyte, Inc. announced the dosing of the first participant in its Phase 1 clinical trial evaluating VAX-A1, a novel vaccine candidate designed to prevent diseases caused by Group A Streptococcus (Group A Strep). This dose-escalation study aims primarily to assess safety and tolerability, with secondary evaluation of immune response in healthy adul…

Netskope Joins Anthropic’s Project Glasswing

Netskope Joins Anthropic’s Project Glasswing

Netskope (NASDAQ: NTSK) has joined Anthropic's Project Glasswing, leveraging Anthropic’s advanced AI model, Mythos Preview, to detect vulnerabilities in code swiftly and at scale. This collaboration enhances Netskope's ability to provide real-time governance and security across AI applications and enterprise traffic, addressing critical gaps in AI …

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Crinetics Pharmaceuticals, a US-based biotech firm specializing in endocrine disorders, has launched 'Everyday Advocacy,' a patient-centered program providing education, support, and tools to empower individuals with endocrine and related conditions. Developed in collaboration with leading patient organizations, the initiative aims to improve patie…

No-Audit Agreement Stands as Weaponization Fund Is Paused, Sources Say

No-Audit Agreement Stands as Weaponization Fund Is Paused, Sources Say

Two sources said the Justice Department’s pact shielding President Donald Trump and his family from future tax audits remains intact even as his $1.8 billion anti-weaponization fund has been placed on hold. White House officials made calls to lawmakers to assert there would be no payouts after a Republican backlash, but lawmakers are pressing for a…

Empire Petroleum Director Purchases Stock Amid Valuation Questions

Empire Petroleum Director Purchases Stock Amid Valuation Questions

A director at Empire Petroleum Corp (NASDAQ:EP) recently acquired a significant block of the company's common stock. This insider purchase occurs while the stock has seen a substantial decline over the past year. Furthermore, the company reported a first-quarter loss and lower production output, presenting a mixed picture for investors.

Kaltura Executive Executes Stock Sale Despite Recent Earnings Beat

Kaltura Executive Executes Stock Sale Despite Recent Earnings Beat

Chief Customer Officer Natan Israeli sold a block of Kaltura common stock through a pre-arranged trading plan. This activity occurred amidst mixed signals for the company, as recent Q1 2026 revenue surpassed analyst expectations, yet the stock experienced declines in aftermarket trading, suggesting cautious investor sentiment.